Holland Capital Management’s Biogen BIIB Stock Holding History

Holland Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$18.8M	Sell	69,449 -3,152	-4%	-$833K	0.83%	49
2017 Q1	$19.9M	Buy	72,601 +20,166	+38%	+$5.7M	0.85%	49
2016 Q4	$14.9M	Sell	52,435 -1,959	-4%	-$581K	0.63%	51
2016 Q3	$17M	Sell	54,394 -5,098	-9%	-$1.51M	0.7%	51
2016 Q2	$14.4M	Sell	59,492 -30,010	-34%	-$7.91M	0.56%	51
2016 Q1	$23.3M	Sell	89,502 -1,221	-1%	-$323K	0.62%	50
2015 Q4	$27.8M	Sell	90,723 -2,900	-3%	-$833K	0.71%	47
2015 Q3	$27.3M	Buy	+93,623	New	+$30.9M	0.71%	50

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Holland Capital Management's BIIB Position: Q2 2017 in Review

Holland Capital Management reduced its Biogen (BIIB) stake by 4.3% in Q2 2017, selling an estimated $833K and leaving 69,449 shares worth $18.8M. The position accounts for 0.83% of the portfolio, ranked #49.

Holland Capital Management first reported a position in BIIB in Q3 2015 and has held it in 8 quarters since. The position peaked at $27.8M in Q4 2015. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Holland Capital Management held 69,449 shares of Biogen worth $18.8M as of Q2 2017.
Holland Capital Management sold 3,152 Biogen shares in Q2 2017, an estimated $833K.
Biogen made up 0.83% of Holland Capital Management's portfolio in Q2 2017, its #49 holding.
Holland Capital Management first reported a position in Biogen in Q3 2015 and has held it in 8 quarters since.
Holland Capital Management's Biogen position peaked at $27.8M in Q4 2015.
992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Holland Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.